Nucleic Acids Research, 1994, Vol. 22, No. 3 301-307
© 1994
RNA |
Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences
1Department of Molecular and Cellular Biology Apollon, One Great Valley Parkway, Malvern, PA 19355, USA 2Max Planck Institut für Molekulare Genetik Ihnestrasse 73, D1000 Berlin 33, Germany 3Institute of Medical Virology, Gloriastrasse 30, University Zurich, Switzerland
Received November 3, 1993. Accepted December 22, 1993.
Conventionally designed ribozymes may be unable to cleave RNA at sites which are inaccessible due to secondary structure. In addition, it may also be difficult to specifically target a conventionally designed ribozyme to some chimeric RNA molecules. Novel approaches for ribozyme targeting were developed by using the L6 bcr-abl fusion RNA as a model. Using one approach, we successfully directed ribozyme nucleation to a site on the bcr-abl RNA that is distant from the GUA cleavage site. These ribozymes bound to the L6 substrate RNA via an anchor sequence that was complementary to bcr sequences. The anchor was necessary for efficient cleavage as the anchor minus ribozyme, a conventionally designed ribozyme, was inefficient at catalyzing cleavage at this same site. The effect of anchor sequences on catalytic rates was determined for two of these ribozymes. Ribozymes generated by a second approach were designed to cleave at a CUU site in proximity to the bcr-abl junction. Both approaches have led to the development of a series of ribozymes specific for both the L6 and K28 bcr-abl chimeric RNAs, but not normal abl or bcr RNAs. The specificity of the ribozyme correlated in part with the ability of the ribozyme to bind substrate as demonstrated by gel shift analyses. Secondary structure predictions for the RNA substrate support the experimental results and may prove useful as a theoretical basis for the design of ribozymes.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Shiota, M. Sano, M. Miyagishi, and K. Taira Ribozymes: Applications to Functional Analysis and Gene Discovery J. Biochem., August 1, 2004; 136(2): 133 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Carella, E. Lerma, M. T. Corsetti, A. Dejana, P. Basta, F. Vassallo, M. Abate, M. Soracco, F. Benvenuto, O. Figari, et al. Autografting With Philadelphia Chromosome-Negative Mobilized Hematopoietic Progenitor Cells in Chronic Myelogenous Leukemia Blood, March 1, 1999; 93(5): 1534 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gewirtz, D. L. Sokol, and M. Z. Ratajczak Nucleic Acid Therapeutics: State of the Art and Future Prospects Blood, August 1, 1998; 92(3): 712 - 736. [Full Text] [PDF] |
||||
![]() |
A. M. Carella Autotransplants in Chronic Myeloid Leukemia Oncologist, February 1, 1998; 3(1): 54 - 60. [Full Text] |
||||


